Argentina Vaccines Market Overview, 2028

Argentina's healthcare system includes a vibrant and essential segment called the vaccine market. In Argentina, vaccination is strongly encouraged as a means of illness prevention, from infant immunisations through adult and travel vaccinations. The market is expanding as a result of a number of factors, including government initiatives, campaigns to avoid disease, an ageing population, and a booming pharmaceutical sector. In this essay, we examine the numerous facets of the vaccine market in Argentina, emphasising its importance and difficulties. Argentina's government has historically demonstrated a strong commitment to vaccination. The National Vaccination Calendar, managed by the Ministry of Health, outlines the recommended vaccines for all age groups, making vaccination accessible to the entire population. The government purchases and provides vaccines free of charge, ensuring broad coverage. Childhood immunisation is a cornerstone of Argentina's vaccination efforts. The country's comprehensive vaccination schedule includes vaccines against diseases like measles, mumps, rubella, polio, and diphtheria, among others. These vaccines are administered at healthcare facilities and play a crucial role in reducing childhood morbidity and mortality. Argentina has vaccine mandates in place for school entry, requiring children to receive specific vaccines before enrolling in educational institutions. These mandates help maintain high vaccine coverage rates among school-aged children. One of the most significant government initiatives is providing free access to vaccines. The government procures vaccines and distributes them through a network of healthcare facilities, making vaccination accessible to the entire population. This initiative ensures that cost is not a barrier to immunization. The government collaborates with domestic pharmaceutical companies, supporting vaccine production and research. This partnership strengthens Argentina's vaccine manufacturing capabilities.

According to the research report "Argentina Vaccines Market Overview, 2028," published by Bonafide Research, the Argentina Vaccines Market was valued at more than USD 470 Million in 2022. Argentina has a long-standing commitment to public health and vaccination. The government places a strong emphasis on vaccination as a preventive healthcare measure. The Ministry of Health oversees the National Vaccination Calendar, ensuring that vaccines are readily available and recommended for all age groups. This commitment is underscored by the government's provision of vaccines free of charge, making them accessible to the entire population. Argentina's National Vaccination Calendar outlines a comprehensive schedule of recommended vaccines for various age groups, from infants to the elderly. This schedule includes vaccines against a wide range of diseases, such as measles, mumps, rubella, polio, and hepatitis, among others. The accessibility of these vaccines at healthcare facilities ensures that individuals receive timely and age-appropriate vaccinations. The country's National Vaccination Calendar outlines a comprehensive schedule of recommended vaccines for various age groups, from infants to the elderly. This schedule includes vaccines against a wide range of diseases, such as measles, mumps, rubella, polio, and hepatitis, among others. The accessibility of these vaccines at healthcare facilities ensures that individuals receive timely and age-appropriate vaccinations. Argentina, like many countries, has an ageing population. With an increasing number of elderly individuals, there is a growing demand for vaccines that protect against diseases commonly affecting older adults. Vaccines against influenza, pneumonia, and shingles are recommended for seniors to safeguard their health.

According to the technology types, they include conjugated vaccines, inactivated and subunit vaccines, live-attenuated vaccines, recombinant vaccines, and toxoid vaccines. In Argentina, the market for live-attenuated vaccines is growing. Live-attenuated vaccines are known for their high efficacy in preventing diseases. These vaccines contain weakened or attenuated forms of the pathogen, which can replicate in the body, triggering a strong and long-lasting immune response. This makes them particularly effective in conferring immunity. Many live-attenuated vaccines are included in Argentina's National Vaccination Calendar. This government endorsement ensures that these vaccines are readily available to the entire population and are administered at the recommended age, contributing to their widespread use. Live-attenuated vaccines are well-suited for childhood immunisation programs. Vaccines like the measles, mumps, and rubella (MMR) vaccine and the varicella vaccine are part of routine childhood vaccinations in Argentina. The effectiveness of these vaccines in preventing highly contagious diseases has led to their widespread adoption.

Based on the route of administration, they are segmented into intramuscular and subcutaneous administration, oral administration, and others. In Count Argentina has implemented national vaccination campaigns that target a wide range of infectious diseases. Some of these campaigns involve the administration of oral vaccines to reach large populations efficiently. The use of oral vaccines is often favoured for mass immunisation programmes, where reaching a large number of people quickly is essential. These programmes may target specific diseases or populations, such as children or avelers. Argentina has implemented various public health initiatives to increase vaccine coverage. These initiatives may include the use of oral vaccines to protect against diseases like rotavirus. Mucosal Immunity: Some diseases, such as rotavirus, enter the body through the gastrointestinal tract. Oral vaccines can stimulate mucosal immunity, which is important for preventing these diseases. According to the report, types are segmented into multivalent vaccines and monovalent vaccines, among them. The monovalent market is growing. Some diseases require dedicated monovalent vaccines due to their unique characteristics or the need for specific antigen formulations. Monovalent vaccines are designed to provide protection against a single pathogen or disease. In cases where a particular disease is of significant concern in Argentina, the use of monovalent vaccines targeting that disease can be a priority. Changes in disease epidemiology or the emergence of new disease threats can drive the demand for monovalent vaccines. If a specific disease becomes more prevalent or poses a particular risk in Argentina, there may be a need for dedicated monovalent vaccines to address that threat. Public health authorities in Argentina may respond to specific disease outbreaks or health concerns by introducing monovalent vaccines tailored to address those issues. This can include vaccines for emerging infectious diseases or those associated with seasonal outbreaks.

In terms of disease types, they include the rotavirus, pneumococcal diseases, cancer, influenza, diphtheria, pertussis, and tetanus, the human papilloma virus (HPV), hepatitis, shingles, meningococcal diseases, varicella, mumps, and others. Among them, pneumococcal diseases are the most common disease types in the country. Pneumococcal diseases, caused by the bacterium Streptococcus pneumoniae, can lead to serious and sometimes life-threatening illnesses such as pneumonia, meningitis, and bacteremia (bloodstream infections). These diseases have been associated with a considerable disease burden in Argentina, particularly among vulnerable populations such as young children and the elderly. The Argentine government has recognised the importance of preventing pneumococcal diseases and has prioritised vaccination as a key public health intervention. This has led to the inclusion of pneumococcal vaccines in the country's national immunisation programs. Argentina has implemented routine pneumococcal vaccination programmes, often targeting infants and young children who are at higher risk of pneumococcal infections. These programmes aim to provide early protection against pneumococcal diseases.



In terms of the end user, who includes paediatric vaccines and adult vaccines, in Argentina, paediatric vaccines are the adding end user. Argentina has a robust and comprehensive national vaccination calendar, which includes a wide range of vaccines recommended for children. The government actively promotes childhood immunisation through vaccination campaigns and public health initiatives. This strong government support ensures that parents are aware of the importance of vaccinating their children and that those vaccines are readily available. Argentina has vaccine mandates in place, requiring children to receive specific vaccines before they can enrol in educational institutions. These mandates are an effective way to ensure that children are up to date with their vaccinations, and they create a strong incentive for parents to vaccinate their children. Parents in Argentina generally have a high level of awareness and trust in vaccines. Public health campaigns and educational initiatives reinforce the safety and effectiveness of vaccines, contributing to parental confidence in vaccinating their children.

Based on the distribution channel, it includes hospital pharmacy, retail pharmacy, institutional sales, and others. In Argentina, hospital pharmacies lead the market. The healthcare system in Argentina is mostly comprised of hospitals and pharmacies. Since they are widely dispersed around the nation, a sizable section of the population may access them. Both hospitals and pharmacies are equipped with the necessary facilities and storage capabilities to maintain the cold chain required for vaccines. Proper temperature control is essential to ensuring the effectiveness and safety of vaccines. Many paediatric vaccines are administered at hospitals and pharmacies, especially for new-borns and infants. Hospitals routinely provide vaccines to new-borns shortly after birth, contributing to early immunisation efforts. Hospitals are often at the forefront of emergency response efforts. In cases of disease outbreaks or public health emergencies, hospitals can serve as vaccination hubs, ensuring rapid vaccine distribution and administration.

Considered in this report:
• Geography: Argentina
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• Argentina Vaccines market Outlook with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Technology
• Conjugate vaccines
• Inactivated & Subunit vaccines
• Live Attenuated vaccines
• Recombinant vaccines
• Toxoid vaccines
• Viral vector vaccines
• Others

By Route of Administration
• Intramuscular and Subcutaneous Administration
• Oral Administration
• Others

By Disease
• Rotavirus
• Pneumococcal diseases
• Cancer
• Influenza
• Diphtheria, Pertussis, and Tetanus (DTP)
• Human Papilloma Virus (HPV)
• Hepatitis
• Shingles
• Meningococcal diseases
• Varicella (Chicken Pox)
• Mumps
• Others

By Type
• Multivalent vaccines
• Monovalent vaccines

By End-User Type
• Paediatrics
• Adults

By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Drone industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.